Literature DB >> 36161531

Comparison of physiological responses after incremental shuttle walking test and 6-minute walk test in patients with systemic sclerosis.

Buse Ozcan Kahraman1, Aylin Tanriverdi2,3, Nazenin Hande Sezgin3, Serap Acar2, Ahmet Merih Birlik4, Aydan Koken Avsar4, Bahri Akdeniz5, Ebru Ozpelit5, Sema Savci2.   

Abstract

BACKGROUND: The 6‑minute walk test (6MWT) is a commonly used to evaluate exercise capacity in patients with systemic sclerosis (SSc), but there was no study using the incremental shuttle walking test (ISWT) for assessing exercise capacity and comparing the patient's cardiorespiratory responses to these tests. The aim was to investigate the usability and determinants of the ISWT in patients with SSc and compare the physiological responses after the ISWT and 6MWT.
METHODS: A total of thirty four female patients with SSc were included. Dyspnea during daily activities and knee extensor muscle strength was assessed, skin fibrosis and disease severity were recorded, and 6MWT and ISWT were carried out for the exercise capacity measurement. Pulmonary function test results were recorded from the individuals' medical records for SSc with interstitial lung disease (SSc-ILD) patients.
RESULTS: The ISWT distance was significantly correlated with the 6MWT distance (p < 0.001). The 6MWT was correlated with age, modified Rodnan skin score, Medsger severity score, modified British Medical Research Council Questionnaire (mMRC) score, and knee extensor muscle strength (p < 0.05). The 6MWT was correlated with the forced expiratory volume in the first second (FEV1) (lt) and forced vital capacity (FVC) (lt) in patients with SSc-ILD (p < 0.05). The ISWT distance was correlated with age, modified Rodnan skin score, mMRC score, and knee extensor muscle strength (p < 0.05). Age, mMRC, and knee extensor muscle strength explained 33.8% of the variance in 6MWT distance, while age, mMRC, and knee extensor muscle strength explained 51.7% of the variance in the ISWT distance.
CONCLUSION: Because of the higher cardiopulmonary responses, and having a more standardized procedure, the ISWT may be preferable for investigating symptom-limited exercise capacity in patients with SSc. Age, dyspnea, and knee extensor muscle strength were the determinants of exercise capacity in patients with SSc.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.

Entities:  

Keywords:  Dyspnea; Exercise test; Muscle strength; Systemic sclerosis; Walk test

Year:  2022        PMID: 36161531     DOI: 10.1007/s00508-022-02087-y

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   2.275


  36 in total

1.  Impaired exercise performance in systemic sclerosis and its clinical correlations.

Authors:  G Cuomo; C Santoriello; F Polverino; L Ruocco; G Valentini; M Polverino
Journal:  Scand J Rheumatol       Date:  2010-08       Impact factor: 3.641

Review 2.  An official systematic review of the European Respiratory Society/American Thoracic Society: measurement properties of field walking tests in chronic respiratory disease.

Authors:  Sally J Singh; Milo A Puhan; Vasileios Andrianopoulos; Nidia A Hernandes; Katy E Mitchell; Catherine J Hill; Annemarie L Lee; Carlos Augusto Camillo; Thierry Troosters; Martijn A Spruit; Brian W Carlin; Jack Wanger; Véronique Pepin; Didier Saey; Fabio Pitta; David A Kaminsky; Meredith C McCormack; Neil MacIntyre; Bruce H Culver; Frank C Sciurba; Susan M Revill; Veronica Delafosse; Anne E Holland
Journal:  Eur Respir J       Date:  2014-10-30       Impact factor: 16.671

3.  Six-minute walk test for the evaluation of pulmonary disease severity in scleroderma patients.

Authors:  Wander O Villalba; Percival D Sampaio-Barros; Mônica C Pereira; Elza M F P Cerqueira; Cid A Leme; João F Marques-Neto; Ilma A Paschoal
Journal:  Chest       Date:  2007-01       Impact factor: 9.410

4.  Cardiopulmonary Exercise Testing.

Authors:  Derek Tran
Journal:  Methods Mol Biol       Date:  2018

Review 5.  Diagnosis and classification of systemic sclerosis.

Authors:  Eric Hachulla; David Launay
Journal:  Clin Rev Allergy Immunol       Date:  2011-04       Impact factor: 8.667

6.  Self-reported physical capacity and activity in patients with systemic sclerosis and matched controls.

Authors:  H Pettersson; A Åkerström; A Nordin; E Svenungsson; H Alexanderson; C Boström
Journal:  Scand J Rheumatol       Date:  2017-03-17       Impact factor: 3.641

7.  Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.

Authors:  Margaret C Garin; Kristin B Highland; Richard M Silver; Charlie Strange
Journal:  J Rheumatol       Date:  2009-01-22       Impact factor: 4.666

8.  Skeletal muscle involvement in progressive systemic sclerosis (scleroderma).

Authors:  T A Medsger; G P Rodnan; J Moossy; J W Vester
Journal:  Arthritis Rheum       Date:  1968-08

9.  Reproducibility and Utility of the 6-minute Walk Test in Systemic Sclerosis.

Authors:  Grégory Pugnet; Zora Marjanovic; Christophe Deligny; Karine Boussardon; Ilham Benzidia; Mathieu Puyade; Pauline Lansiaux; Els Vandecasteele; Vanessa Smith; Dominique Farge
Journal:  J Rheumatol       Date:  2018-07-01       Impact factor: 4.666

10.  Lower limb muscle strength is associated with functional performance and quality of life in patients with systemic sclerosis.

Authors:  Tatiana R L Lima; Fernando S Guimarães; Mara N Carvalho; Thaís L M Sousa; Sara L S Menezes; Agnaldo J Lopes
Journal:  Braz J Phys Ther       Date:  2015-03-13       Impact factor: 3.377

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.